Items where Author is "de Vos, M."

2023

Labhardt, N. D. and González Fernández, L. and Katende, B. and Muhairwe, J. and Bresser, M. and Amstutz, A. and Glass, T. R. and Ruhwald, M. and Sacks, J. A. and Escadafal, C. and Mareka, M. and Mooko, S. M. and de Vos, M. and Reither, K.. (2023) Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho. PLoS One, 18 (3). e0278653.

Katende, B. and Bresser, M. and Kamele, M. and Chere, L. and Tlahali, M. and Erhardt, R. M. and Muhairwe, J. and Ayakaka, I. and Glass, T. R. and Ruhwald, M. and van Ginneken, B. and Murphy, K. and de Vos, M. and Amstutz, A. and Mareka, M. and Mooko, S. M. and Reither, K. and González Fernández, L.. (2023) Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho. PLOS Glob Public Health, 3 (8). e0001488.

2022

Katende, B. and Fernández, L. G. and Muhairwe, J. and Glass, T. R. and Ayakaka, I. and Labhardt, N. D. and Ruhwald, M. and de Vos, M. and Bresser, M. and Reither, K.. (2022) Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study. IJID Reg, 5. pp. 163-164.

2021

Ley, S. D. and Pillay, S. and Streicher, E. M. and van der Heijden, Y. F. and Sirgel, F. and Derendinger, B. and de Kock, M. and Gagneux, S. and Warren, R. M. and Theron, G. and de Vos, M.. (2021) Melting the eis: non-detection of kanamycin resistance markers by routine diagnostic tests and identification of new eis-promoter variants. Antimicrob Agents Chemother, 65 (7). e0250220.

2013

de Vos, M. and Müller, B. and Borrell, S. and Black, P. and van Helden, P. and Warren, R. and Gagneux, S. and Victor, T.. (2013) Putative compensatory mutations in the rpoC gene of rifampicin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrobial agents and chemotherapy : AAC, Vol. 57, H. 2. pp. 827-832.